Immune infiltrating cells in duodenal cancers

BACKGROUND: Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough understanding of the pathogenesis of the disease and of its biology, limiting the identification of tailored therapeutic options. A l...

Descripción completa

Detalles Bibliográficos
Autores principales: Donisi, G., Capretti, G., Cortese, N., Rigamonti, A., Gavazzi, F., Nappo, G., Pulvirenti, A., Sollai, M., Spaggiari, P., Zerbi, A., Marchesi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470614/
https://www.ncbi.nlm.nih.gov/pubmed/32883314
http://dx.doi.org/10.1186/s12967-020-02508-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470614/
https://www.ncbi.nlm.nih.gov/pubmed/32883314
http://dx.doi.org/10.1186/s12967-020-02508-4

Ejemplares similares